Research Spotlight: Severity of COVID-19–Related Illness in Massachusetts, July 2021 to December 2022
Researchers found that vaccination is still associated with a decrease in the risk of severe SARS-CoV-2 outcomes.
NewsMay | 14 | 2020
As part of its COVID-19 response, the Ragon Institute of MGH, MIT and Harvard is working within the Massachusetts Consortium for Pathogen Readiness (MassCPR), a multi-institutional initiative convened by Harvard Medical School and the Ragon Institute, to combat the disease and prepare for future outbreaks.
The MassCPR recently announced the awarding of more than $16.5 million in funding to support 62 research projects that address the most pressing challenges of the pandemic. Six of the awards were given to Ragon Institute members with affiliations.
Ragon Institute director, Bruce Walker, MD, serves as co-director and founding member, and many of our members, steering committee members and group leaders are working within the MassCPR to combat COVID-19.
“I think most of us pursued careers in science hoping that we would someday have the opportunity to work on something that truly had meaning and that would allow us to work together in collaboration rather than competition,” said Walker. “I feel we have found that here in the MassCPR.”
Funding was provided by the China Evergrande Group and donations, including support of $1 million or more each from Mark and Lisa Schwartz, the MLSC and the Bertarelli Foundation.
“We’re thrilled to be supporting MassCPR in unraveling the mysteries of SARS CoV2. We believe we’re investing in the best doctors and scientists in the world, and we hope our financial support will help establish the best testing protocols, the most effective treatments and the safest vaccines,” says donors Mark and Lisa Schwartz.
The total list of projects can be found at https://masscpr.hms.harvard.edu/research.
We harness the immune system to prevent and cure human disease. Currently, we are using our resources and scientists to focus on SARS-CoV-2.
Researchers found that vaccination is still associated with a decrease in the risk of severe SARS-CoV-2 outcomes.
Many workers at group homes in Massachusetts serving adults with mental illness or disability perceived very serious effects of the first year of the pandemic on their own health and access to care.
I need to make an appointment for a non-COVID-19 health condition. Is it safe to come to the hospital? Answers to this and other FAQs about how Mass General is prepared to provide general care to patients.
Maternal SARS‐CoV‐2 positivity during pregnancy was associated with nearly two-fold higher odds of a neurodevelopmental diagnosis at 12 months of age among male children.
Researchers have examined how patient characteristics and COVID-19 infection may affect the antibody responses of people with HIV—including responses against SARS-CoV-2 proteins as well as proteins from other viruses.
Researchers have developed an upgraded chest radiograph (CXR) explainable artificial intelligence model that was trained on thousands of well annotated CXRs.